Call For Your Free Consultation
(314) 963-9000

Defective Drugs

Filter by category

Common Herpes Injectable Recalled for Clotting, Stroke Risk

Posted on March 29th, 2021

Four lots of acyclovir sodium injection produced by Zydus Pharmaceuticals (USA) Inc. have been voluntarily recalled after the company received notification from several hospitals and other administrators that the product had crystallized inside 50 mg/mL, 10 mL and 20 mL vials. In the event that crystalized acyclovir sodium injection were administered to a patient, it… Read More


Women Join Paragard Lawsuits after IUD Breaks

Posted on January 19th, 2021

Women who needed hysterectomy, hysteroscopy, laparoscopy, and laparotomy may be eligible for compensation. For decades, women have been implanted with an interuterine device (IUD) called Paragard T 380A, or simply “Paragard.” These women, and their doctors, trusted that The Cooper Company, who makes the device, was being honest and forthright about its safety. Yet tens… Read More


What Happens if my Case isn’t Chosen for Trial?

Posted on November 30th, 2020

Multi-district litigations (MDLs), such as lawsuits against Bayer-Monsanto or Johnson & Johnson talc cases, can be a bit confusing for those who aren’t familiar with legal lingo and processes.  We’ve talked quite a bit about bellwether trials, including the fact that, of the often tens of thousands of cases involved in these large-scale litigations, the… Read More


Is Your Online Pharmacy Safe?

Posted on September 28th, 2020

The U.S. The Food and Drug Administration has launched a national campaign called BeSafeRx to educate consumers on the dangers of online pharmacies. As drug costs continue to rise, many consumers are turning to online resources for their medications because of the convenience, as well as for the cost savings. The effort began following an… Read More


Novartis to Pay $642 million for Kickbacks, Medicare Schemes

Posted on August 7th, 2020

Novartis Pharmaceuticals Corporation has agreed to pay more than $642 million to settle two separate claims brought by the U.S. Department of Justice that the company violated the False Claims Act. According to the lawsuits filed against the pharmacy giant, Novartis hid behind charitable foundations to illegally funnel co-payments for Medicare patients taking two of… Read More


Missouri Courts Plan Re-Opening

Posted on July 29th, 2020

When coronavirus arrived in the United States in March, effects of the lockdown crippled both the public and private sectors. The nation’s court system was no exception, as in-person hearings and jury trials were halted across the country. Civil and criminal cases were delayed, leaving both plaintiffs and defendants in legal limbo for months.  For… Read More


Truvada Trial Affected by COVID-19

Posted on July 29th, 2020

As COVID-19 continues to impact in-person court action, bellwether trials for mass torts and other civil court cases will likely be postponed. These continuations include a bellwether trial previously slated to be heard next winter, in January 2022, against Gilead for damage done by anti-HIV drug Truvada, or PrEP. Currently, the court has ordered the… Read More


Truvada Litigation Update

Posted on March 31st, 2020

Truvada litigation continues to move forward. Tuesday, March 31, 2020 – As we reported last month, the overall litigation is still in its early stages, and of course the COVID-19 pandemic has added its own complication with the California courts being closed at least through April 15, 2020. We have not yet been notified of an… Read More


Truvada Cases Moving Forward

Posted on March 5th, 2020

TDF litigation is in early stages. Thursday, March 5, 2020 – Litigation continues to move forward for plaintiffs who have suffered kidney, bone, and/or teeth issues after using Truvada and other drugs with the active ingredient tenofovir disoproxil fumarate (TDF). The OnderLaw Truvada litigation team has been working to obtain and review pharmacy and medical records… Read More


Congresswoman Urges FDA to Ban Zantac, Ranitidine Products

Posted on January 10th, 2020

Rosa DeLauro (CT-03)has asked the FDA to remove all ranitidine-based products from shelves. Friday, January 10, 2020 – One congresswoman has led a push to ban Zantac and other ranitidine-based medications in the U.S. due to concerns that they are causing cancer. Heartburn drug Zantac and other products containing a drug called ranitidine have taken… Read More


It's not just a case, it's your life.

Talk to a Lawyer for Free

What is Your Case Worth?